Literature DB >> 29349620

Fatal Talaromyces marneffei Infection in a Patient with Autoimmune Hepatitis.

Sally C Y Wong1, Siddharth Sridhar1,2,3, Antonio H Y Ngan1, Jonathan H K Chen1, Rosana W S Poon1, Susanna K P Lau1,2,3, Patrick C Y Woo4,5,6.   

Abstract

Talaromyces marneffei, previously known as Penicillium marneffei, is the most important pathogenic thermally dimorphic fungus causing systemic mycosis in Southeast Asia. Traditionally, T. marneffei infection in human was mainly associated with acquired immunodeficiency syndrome caused by HIV infection. In recent years, there has been an increasing number of T. marneffei infections reported in non-HIV-infected patients with other immunocompromised conditions, including autoantibodies against interferon-gamma, systemic lupus erythematosis, solid organ transplantation, Job's syndrome, hematological malignancies, and use of novel targeted therapies. In this article, we describe the first case of fatal T. marneffei infection in a patient with underlying autoimmune hepatitis, presented as fever without localizing features. The diagnosis of talaromycosis was confirmed with the identification of the fungi isolated from the blood culture specimen by conventional methods and using matrix-assisted laser desorption-ionization time-of-flight mass spectrometer. This case shows the importance of a high index of suspicion, particularly for such a highly fatal but potentially treatable fungal infection.

Entities:  

Keywords:  Autoimmune hepatitis; Fatal infection; Matrix-assisted laser desorption–ionization time-of-flight mass spectrometer; Talaromyces marneffei

Mesh:

Year:  2018        PMID: 29349620     DOI: 10.1007/s11046-017-0239-0

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  18 in total

Review 1.  Penicilliosis marneffei--West meets East.

Authors:  S S Y Wong; H Siau; K Y Yuen
Journal:  J Med Microbiol       Date:  1999-11       Impact factor: 2.472

2.  Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients.

Authors:  S S Wong; K H Wong; W T Hui; S S Lee; J Y Lo; L Cao; K Y Yuen
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam.

Authors:  Thuy Le; Marcel Wolbers; Nguyen Huu Chi; Vo Minh Quang; Nguyen Tran Chinh; Nguyen Phu Huong Lan; Pham Si Lam; Michael J Kozal; Cecilia M Shikuma; Jeremy N Day; Jeremy Farrar
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

4.  Role of Cannomys badius as a natural animal host of Penicillium marneffei in India.

Authors:  Harish Gugnani; Matthew C Fisher; Anubha Paliwal-Johsi; Nongnuch Vanittanakom; Irabanta Singh; Pratap Singh Yadav
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Human penicilliosis marneffei and its relation to the bamboo rat (Rhizomys pruinosus).

Authors:  Z L Deng; M Yun; L Ajello
Journal:  J Med Vet Mycol       Date:  1986-10

6.  Penicillium marneffei infection: an emerging disease in mainland China.

Authors:  Yongxuan Hu; Junmin Zhang; Xiqing Li; Yabo Yang; Yong Zhang; Jianchi Ma; Liyan Xi
Journal:  Mycopathologia       Date:  2012-09-17       Impact factor: 2.574

7.  Penicillium marneffei infection in patients infected with human immunodeficiency virus.

Authors:  K Supparatpinyo; S Chiewchanvit; P Hirunsri; C Uthammachai; K E Nelson; T Sirisanthana
Journal:  Clin Infect Dis       Date:  1992-04       Impact factor: 9.079

8.  Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei.

Authors:  S Chariyalertsak; P Vanittanakom; K E Nelson; T Sirisanthana; N Vanittanakom
Journal:  J Med Vet Mycol       Date:  1996 Mar-Apr

9.  Disseminated Infections with Talaromyces marneffei in Non-AIDS Patients Given Monoclonal Antibodies against CD20 and Kinase Inhibitors.

Authors:  Jasper F W Chan; Thomas S Y Chan; Harinder Gill; Frank Y F Lam; Nigel J Trendell-Smith; Siddharth Sridhar; Herman Tse; Susanna K P Lau; Ivan F N Hung; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

10.  Differences in clinical characteristics and prognosis of Penicilliosis among HIV-negative patients with or without underlying disease in Southern China: a retrospective study.

Authors:  Ye Qiu; Haifei Liao; Jianquan Zhang; Xiaoning Zhong; Caimei Tan; Decheng Lu
Journal:  BMC Infect Dis       Date:  2015-11-16       Impact factor: 3.090

View more
  3 in total

1.  Sixty Years from Segretain's Description: What Have We Learned and Should Learn About the Basic Mycology of Talaromyces marneffei?

Authors:  Chi-Ching Tsang; Susanna K P Lau; Patrick C Y Woo
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

Review 2.  Re-drawing the Maps for Endemic Mycoses.

Authors:  Nida Ashraf; Ryan C Kubat; Victoria Poplin; Antoine A Adenis; David W Denning; Laura Wright; Orion McCotter; Ilan S Schwartz; Brendan R Jackson; Tom Chiller; Nathan C Bahr
Journal:  Mycopathologia       Date:  2020-02-10       Impact factor: 2.574

3.  First case report of Talaromyces marneffei infection in HIV-infected patient in the city of Ouagadougou (Burkina Faso).

Authors:  Kiswendsida Thierry Guiguemde; Patindoilba Marcel Sawadogo; Adama Zida; Mamadou Cisse; Ibrahim Sangare; Sanata Bamba
Journal:  Med Mycol Case Rep       Date:  2019-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.